Lv51
1190 积分 2025-03-07 加入
PCSK9 in metabolism and diseases
13天前
已完结
Are PCSK9 Inhibitors the Next Breakthrough in the Cardiovascular Field?
13天前
已完结
PCSK9 Inhibition to Reduce Cardiovascular Events
13天前
已完结
Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
13天前
已完结
PCSK9 in metabolism and diseases
13天前
已完结
CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys
1个月前
已完结
Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease
1个月前
已完结
Development of Lipoprotein(a) siRNAs for Mechanism of Action Studies in Non-Human Primate Models of Atherosclerosis
1个月前
已完结
Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)
1个月前
已完结
A live-cell high-throughput screening assay for identification of fatty acid uptake inhibitors
1个月前
已完结
皖公网安备34019202002308
